Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability
Achieve Life Sciences announced the publication of a study in Nicotine & Tobacco Research detailing the receptor selectivity of cytisinicline, a treatment for nicotine dependence. The research explains cytisinicline's strong binding to nicotinic receptors and minimal interaction with serotonin receptors linked to nausea, potentially improving toler…